English

AVROBIO, INC.

EDGAR

AVRO Quarterly report (10-Q) · filed 2026-08-06

43 filing records in this dataset, filed from 2018-05-25 to 2026-08-06. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 227 million USD 2026-06-30 Source
Exact value

227100000 USD
Long-term debt including current maturities: 15 million USD 2023-03-31 Source
Exact value

15000000 USD
Shares outstanding: 19.2 million shares 2026-06-30 Source
Exact value

19235221 shares

Reported share-count change

2.80% · 523 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

18712138 shares · 2025-06-30· Source
19235221 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-85.8 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -19000000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -74200000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -54900000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -25241000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -22300000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-72.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -45617000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -27802000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -60078000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -45617000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -18413000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -39864000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -18413000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

279 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 208000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 27000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 208000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 208000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 98000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-72.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -45617000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -27802000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -60078000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -45617000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -18413000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -39864000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -18413000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 208000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 27000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 208000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 208000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 98000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2022-12-31
Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 16.2 million

Prior period

−USD 58 million

2024-01-01 – 2024-12-31
Current period

−USD 74.2 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-74200000 − -58000000 = -16200000 USD

-58000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-74200000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AVROBIO, INC. · 2025-12-31 AVROBIO, INC. (edgar:1681087) Year-over-year change in Net income: -16200000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -74200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2245735 Filing: 000119312526076793 Input fundies:NetIncome: -58000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2246549 Filing: 000119312526076793
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 998,000

Prior period

−USD 59.08 million

2024-01-01 – 2024-12-31
Current period

−USD 60.08 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-60078000 − -59080000 = -998000 USD

-59080000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-60078000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AVROBIO, INC. · 2025-12-31 AVROBIO, INC. (edgar:1681087) Year-over-year change in Operating cash flow: -998000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -60078000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2134126 Filing: 000119312526076793 Input fundies:OperatingCashFlow: -59080000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2136015 Filing: 000119312526076793
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+33.3%

Prior period

USD 156,000

2024-01-01 – 2024-12-31
Current period

USD 208,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

208000 − 156000 = 52000 USD

156000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
208000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AVROBIO, INC. · 2025-12-31 AVROBIO, INC. (edgar:1681087) Year-over-year change in Capital expenditure: 52000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 208000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2140848 Filing: 000119312526076793 Input fundies:CapitalExpenditure: 156000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2142587 Filing: 000119312526076793
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 18.65 million Exact value Exact value: -18648000 USD 2017-01-01 – 2017-12-31: -18648000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVROBIO, INC. · 2017-12-31 AVROBIO, INC. (edgar:1681087) Net Income: -18648000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18648000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312519085321/avro-20181231.xml#96893 Filing: 000119312519085321 The citation records this snapshot. The page link may show a newer release later.	−USD 16.38 million Exact value Exact value: -16382000 USD 2017-01-01 – 2017-12-31: -16382000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVROBIO, INC. · 2017-12-31 AVROBIO, INC. (edgar:1681087) Operating Cash Flow: -16382000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16382000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312519085321/avro-20181231.xml#96624 Filing: 000119312519085321 The citation records this snapshot. The page link may show a newer release later.	USD 383,000 Exact value Exact value: 383000 USD 2017-01-01 – 2017-12-31: 383000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVROBIO, INC. · 2017-12-31 AVROBIO, INC. (edgar:1681087) Capital Expenditure: 383000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 383000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312519085321/avro-20181231.xml#98006 Filing: 000119312519085321 The citation records this snapshot. The page link may show a newer release later.	−USD 16.77 million Calculation and evidence -16382000 − 383000 USD Exact free cash flow: -16765000 USD 2017-01-01 – 2017-12-31: -16382000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 383000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVROBIO, INC. · 2017-12-31 AVROBIO, INC. (edgar:1681087) Free cash flow: -16765000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16382000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312519085321/avro-20181231.xml#96624 Filing: 000119312519085321 Input fundies:CapitalExpenditure: 383000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312519085321/avro-20181231.xml#98006 Filing: 000119312519085321 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 46.36 million Exact value Exact value: -46361000 USD 2018-01-01 – 2018-12-31: -46361000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVROBIO, INC. · 2018-12-31 AVROBIO, INC. (edgar:1681087) Net Income: -46361000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46361000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459020011144/avro-20191231.xml#118113 Filing: 000156459020011144 The citation records this snapshot. The page link may show a newer release later.	−USD 37.65 million Exact value Exact value: -37648000 USD 2018-01-01 – 2018-12-31: -37648000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVROBIO, INC. · 2018-12-31 AVROBIO, INC. (edgar:1681087) Operating Cash Flow: -37648000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37648000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459020011144/avro-20191231.xml#141680 Filing: 000156459020011144 The citation records this snapshot. The page link may show a newer release later.	USD 1.83 million Exact value Exact value: 1832000 USD 2018-01-01 – 2018-12-31: 1832000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVROBIO, INC. · 2018-12-31 AVROBIO, INC. (edgar:1681087) Capital Expenditure: 1832000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1832000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459020011144/avro-20191231.xml#142102 Filing: 000156459020011144 The citation records this snapshot. The page link may show a newer release later.	−USD 39.48 million Calculation and evidence -37648000 − 1832000 USD Exact free cash flow: -39480000 USD 2018-01-01 – 2018-12-31: -37648000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1832000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVROBIO, INC. · 2018-12-31 AVROBIO, INC. (edgar:1681087) Free cash flow: -39480000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37648000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459020011144/avro-20191231.xml#141680 Filing: 000156459020011144 Input fundies:CapitalExpenditure: 1832000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459020011144/avro-20191231.xml#142102 Filing: 000156459020011144 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 72.97 million Exact value Exact value: -72965000 USD 2019-01-01 – 2019-12-31: -72965000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVROBIO, INC. · 2019-12-31 AVROBIO, INC. (edgar:1681087) Net Income: -72965000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -72965000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459021014190/avro-10k_20201231.htm#1745587 Filing: 000156459021014190 The citation records this snapshot. The page link may show a newer release later.	−USD 67.67 million Exact value Exact value: -67668000 USD 2019-01-01 – 2019-12-31: -67668000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVROBIO, INC. · 2019-12-31 AVROBIO, INC. (edgar:1681087) Operating Cash Flow: -67668000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -67668000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459021014190/avro-10k_20201231.htm#1886841 Filing: 000156459021014190 The citation records this snapshot. The page link may show a newer release later.	USD 1.59 million Exact value Exact value: 1585000 USD 2019-01-01 – 2019-12-31: 1585000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVROBIO, INC. · 2019-12-31 AVROBIO, INC. (edgar:1681087) Capital Expenditure: 1585000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1585000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459021014190/avro-10k_20201231.htm#1894581 Filing: 000156459021014190 The citation records this snapshot. The page link may show a newer release later.	−USD 69.25 million Calculation and evidence -67668000 − 1585000 USD Exact free cash flow: -69253000 USD 2019-01-01 – 2019-12-31: -67668000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1585000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVROBIO, INC. · 2019-12-31 AVROBIO, INC. (edgar:1681087) Free cash flow: -69253000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -67668000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459021014190/avro-10k_20201231.htm#1886841 Filing: 000156459021014190 Input fundies:CapitalExpenditure: 1585000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459021014190/avro-10k_20201231.htm#1894581 Filing: 000156459021014190 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 119.71 million Exact value Exact value: -119712000 USD 2020-01-01 – 2020-12-31: -119712000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVROBIO, INC. · 2020-12-31 AVROBIO, INC. (edgar:1681087) Net Income: -119712000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -119712000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459022010895/avro-10k_20211231.htm#1738438 Filing: 000156459022010895 The citation records this snapshot. The page link may show a newer release later.	−USD 98.8 million Exact value Exact value: -98803000 USD 2020-01-01 – 2020-12-31: -98803000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVROBIO, INC. · 2020-12-31 AVROBIO, INC. (edgar:1681087) Operating Cash Flow: -98803000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -98803000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459022010895/avro-10k_20211231.htm#1870097 Filing: 000156459022010895 The citation records this snapshot. The page link may show a newer release later.	USD 1.18 million Exact value Exact value: 1177000 USD 2020-01-01 – 2020-12-31: 1177000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVROBIO, INC. · 2020-12-31 AVROBIO, INC. (edgar:1681087) Capital Expenditure: 1177000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1177000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459022010895/avro-10k_20211231.htm#1877837 Filing: 000156459022010895 The citation records this snapshot. The page link may show a newer release later.	−USD 99.98 million Calculation and evidence -98803000 − 1177000 USD Exact free cash flow: -99980000 USD 2020-01-01 – 2020-12-31: -98803000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1177000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVROBIO, INC. · 2020-12-31 AVROBIO, INC. (edgar:1681087) Free cash flow: -99980000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -98803000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459022010895/avro-10k_20211231.htm#1870097 Filing: 000156459022010895 Input fundies:CapitalExpenditure: 1177000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000156459022010895/avro-10k_20211231.htm#1877837 Filing: 000156459022010895 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 119.13 million Exact value Exact value: -119126000 USD 2021-01-01 – 2021-12-31: -119126000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVROBIO, INC. · 2021-12-31 AVROBIO, INC. (edgar:1681087) Net Income: -119126000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -119126000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524034461/d770053ds4.htm#4657205 Filing: 000119312524034461 The citation records this snapshot. The page link may show a newer release later.	−USD 98.03 million Exact value Exact value: -98025000 USD 2021-01-01 – 2021-12-31: -98025000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVROBIO, INC. · 2021-12-31 AVROBIO, INC. (edgar:1681087) Operating Cash Flow: -98025000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -98025000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524034461/d770053ds4.htm#4709594 Filing: 000119312524034461 The citation records this snapshot. The page link may show a newer release later.	USD 2.46 million Exact value Exact value: 2461000 USD 2021-01-01 – 2021-12-31: 2461000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVROBIO, INC. · 2021-12-31 AVROBIO, INC. (edgar:1681087) Capital Expenditure: 2461000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2461000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524034461/d770053ds4.htm#4711683 Filing: 000119312524034461 The citation records this snapshot. The page link may show a newer release later.	−USD 100.49 million Calculation and evidence -98025000 − 2461000 USD Exact free cash flow: -100486000 USD 2021-01-01 – 2021-12-31: -98025000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 2461000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVROBIO, INC. · 2021-12-31 AVROBIO, INC. (edgar:1681087) Free cash flow: -100486000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -98025000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524034461/d770053ds4.htm#4709594 Filing: 000119312524034461 Input fundies:CapitalExpenditure: 2461000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524034461/d770053ds4.htm#4711683 Filing: 000119312524034461 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 32.18 million Exact value Exact value: -32180000 USD 2022-01-01 – 2022-12-31: -32180000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVROBIO, INC. · 2022-12-31 AVROBIO, INC. (edgar:1681087) Net Income: -32180000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32180000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524181624/d214571ds1.htm#3441455 Filing: 000119312524181624 The citation records this snapshot. The page link may show a newer release later.	−USD 27.64 million Exact value Exact value: -27637000 USD 2022-01-01 – 2022-12-31: -27637000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVROBIO, INC. · 2022-12-31 AVROBIO, INC. (edgar:1681087) Operating Cash Flow: -27637000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27637000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524181624/d214571ds1.htm#3462387 Filing: 000119312524181624 The citation records this snapshot. The page link may show a newer release later.	USD 2.09 million Exact value Exact value: 2088000 USD 2022-01-01 – 2022-12-31: 2088000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVROBIO, INC. · 2022-12-31 AVROBIO, INC. (edgar:1681087) Capital Expenditure: 2088000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2088000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524181624/d214571ds1.htm#3465257 Filing: 000119312524181624 The citation records this snapshot. The page link may show a newer release later.	−USD 29.73 million Calculation and evidence -27637000 − 2088000 USD Exact free cash flow: -29725000 USD 2022-01-01 – 2022-12-31: -27637000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 2088000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVROBIO, INC. · 2022-12-31 AVROBIO, INC. (edgar:1681087) Free cash flow: -29725000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27637000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524181624/d214571ds1.htm#3462387 Filing: 000119312524181624 Input fundies:CapitalExpenditure: 2088000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312524181624/d214571ds1.htm#3465257 Filing: 000119312524181624 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 42.8 million Exact value Exact value: -42800000 USD 2023-01-01 – 2023-12-31: -42800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVROBIO, INC. · 2023-12-31 AVROBIO, INC. (edgar:1681087) Net Income: -42800000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42800000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312525064163/d863285ds1.htm#1739584 Filing: 000119312525064163 The citation records this snapshot. The page link may show a newer release later.	−USD 40.68 million Exact value Exact value: -40681000 USD 2023-01-01 – 2023-12-31: -40681000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVROBIO, INC. · 2023-12-31 AVROBIO, INC. (edgar:1681087) Operating Cash Flow: -40681000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40681000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312525064163/d863285ds1.htm#1677872 Filing: 000119312525064163 The citation records this snapshot. The page link may show a newer release later.	USD 279,000 Exact value Exact value: 279000 USD 2023-01-01 – 2023-12-31: 279000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVROBIO, INC. · 2023-12-31 AVROBIO, INC. (edgar:1681087) Capital Expenditure: 279000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 279000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312525064163/d863285ds1.htm#1681615 Filing: 000119312525064163 The citation records this snapshot. The page link may show a newer release later.	−USD 40.96 million Calculation and evidence -40681000 − 279000 USD Exact free cash flow: -40960000 USD 2023-01-01 – 2023-12-31: -40681000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 279000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVROBIO, INC. · 2023-12-31 AVROBIO, INC. (edgar:1681087) Free cash flow: -40960000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40681000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312525064163/d863285ds1.htm#1677872 Filing: 000119312525064163 Input fundies:CapitalExpenditure: 279000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312525064163/d863285ds1.htm#1681615 Filing: 000119312525064163 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 58 million Exact value Exact value: -58000000 USD 2024-01-01 – 2024-12-31: -58000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVROBIO, INC. · 2024-12-31 AVROBIO, INC. (edgar:1681087) Net Income: -58000000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -58000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2246549 Filing: 000119312526076793 The citation records this snapshot. The page link may show a newer release later.	−USD 59.08 million Exact value Exact value: -59080000 USD 2024-01-01 – 2024-12-31: -59080000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVROBIO, INC. · 2024-12-31 AVROBIO, INC. (edgar:1681087) Operating Cash Flow: -59080000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -59080000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2136015 Filing: 000119312526076793 The citation records this snapshot. The page link may show a newer release later.	USD 156,000 Exact value Exact value: 156000 USD 2024-01-01 – 2024-12-31: 156000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVROBIO, INC. · 2024-12-31 AVROBIO, INC. (edgar:1681087) Capital Expenditure: 156000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 156000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2142587 Filing: 000119312526076793 The citation records this snapshot. The page link may show a newer release later.	−USD 59.24 million Calculation and evidence -59080000 − 156000 USD Exact free cash flow: -59236000 USD 2024-01-01 – 2024-12-31: -59080000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 156000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVROBIO, INC. · 2024-12-31 AVROBIO, INC. (edgar:1681087) Free cash flow: -59236000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -59080000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2136015 Filing: 000119312526076793 Input fundies:CapitalExpenditure: 156000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2142587 Filing: 000119312526076793 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 74.2 million Exact value Exact value: -74200000 USD 2025-01-01 – 2025-12-31: -74200000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVROBIO, INC. · 2025-12-31 AVROBIO, INC. (edgar:1681087) Net Income: -74200000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -74200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2245735 Filing: 000119312526076793 The citation records this snapshot. The page link may show a newer release later.	−USD 60.08 million Exact value Exact value: -60078000 USD 2025-01-01 – 2025-12-31: -60078000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVROBIO, INC. · 2025-12-31 AVROBIO, INC. (edgar:1681087) Operating Cash Flow: -60078000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -60078000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2134126 Filing: 000119312526076793 The citation records this snapshot. The page link may show a newer release later.	USD 208,000 Exact value Exact value: 208000 USD 2025-01-01 – 2025-12-31: 208000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVROBIO, INC. · 2025-12-31 AVROBIO, INC. (edgar:1681087) Capital Expenditure: 208000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 208000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2140848 Filing: 000119312526076793 The citation records this snapshot. The page link may show a newer release later.	−USD 60.29 million Calculation and evidence -60078000 − 208000 USD Exact free cash flow: -60286000 USD 2025-01-01 – 2025-12-31: -60078000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 208000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVROBIO, INC. · 2025-12-31 AVROBIO, INC. (edgar:1681087) Free cash flow: -60286000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -60078000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2134126 Filing: 000119312526076793 Input fundies:CapitalExpenditure: 208000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm#2140848 Filing: 000119312526076793 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

43 filings · 2,037 latest values · 2,037 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001681087, 1681087, AVRO, TECX, edgar:1681087

Also known as AVROBIO, INC., AVROBIO, Inc., AVROBIO, INC., AvroBio, Inc., TECTONIC THERAPEUTIC, INC., Tectonic Therapeutic, Inc.

AVROBIO, INC.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation